National Cancer InstituteU.S. National Institutes of Health | www.cancer.gov
U.S. National Institutes of Health www.cancer.gov

Home | About ICSN | Collaborative Projects | Meetings | Cancer Sites | Publications | Contact Us
Breast Cancer: Mortality Rates | Screening Programs | Other Characteristics | Policies | Performance Measures | Impact Measures | Abnormal Result Technologies & Procedures

Performance Measures used in Breast Cancer Screening Programs in 26 ICSN Countries, 2012*

Region/Country PPV (Screening Text) PPV (Additional Imaging) PPV (recall) PPV (open biopsy) PPV (core biopsy) PPV (cytology) Partici-pation rate Recall Rate Open Biopsy Rate Sensitivity Specificity Imaging Rate Cytology Rate Benign Biopsy Rate Cancer Detection Rate Benign/malignant Ratio
Australia X X X X X X X X X X X X X X X
Canada X X X X X
China X X X
Denmark X X X X X X
Finland X X X X
France X X X X X X X X X X
Iceland X X X X X X X X X
Israel X X X X X X X X
Italy X X X X X X X X X X X X X
Japan X X X X X X
Korea X X X X X X
Luxembourg X X X X X X X X X X X X
Netherlands X X X X X X X X X X
New Zealand X X X X X X X X X X X
Norway X X X X X X X X X X X X X X X
Poland X X X X X X X X X X X X X X X X
Portugal (Central Region) X X X X X X X X X X X X
Portugal (Alentejo Region) X X X X X X X X X X X X
Saudi Arabia X X X X X X X
Spain (Catalonia) X X X X X X X
Spain (Navarra) X X X X X X X X X X X X X X X
Sweden 1
Switzerland X X X X X X X X X X X X X X X X
United Kingdom X X X X X X X X X
United States2 X X X X X X X X
Uruguay X X X X X X X X X

*Data are from a survey of ICSN country representatives, conducted in 2012

1 Varies by program.

2 Data comes from the Breast Cancer Surveillance Consortium.